Is BRN still a Spec Stock ????, page-38

Back to the thread title, I consider BRN a speccy. No meaningful fundamental valuation can be placed on it at this time; the RoI could be nothing, or absolutely huge. If the tech does what it is meant to, EAPs turn into commitments the stock will be worth many multiples of where it is now. A couple of deals with the likes of Ford, Samsung, (for example only) to play a mainstream role in their cars and phones and we are looking at, I believe, a company that will be finding its way quickly to $5, $10 plus (IMHO). The current share price reflects, IMO, med-high risk, but incredible rewards.

BRN is what I would classiy as a late-stage speccy, however. I expect confirmation, or rejection, in the near term - I love speccys, but am not a patient man. BRN, semi de-risked, is the way I like my shares. The upside, hmmm, the upside...